Robert O. Ryan

Characterization of secondary structure and lipid binding behavior of N-terminal saposin like subdomain of human Wnt3a.

Evaluation of cardiolipin nanodisks as lipid replacement therapy for Barth syndrome.

Effect of curcumin on amyloid-like aggregates generated from methionine-oxidized apolipoprotein A-I.

Calcium-induced transformation of cardiolipin nanodisks.

High density lipoprotein promotes nascent apolipoprotein A-V secretion from mRNA transfected cells.

3-Methylglutaric acid in energy metabolism.

Dye binding assay reveals doxorubicin preference for DNA versus cardiolipin.

Assembly and Characterization of Biocompatible Coenzyme Q -Enriched Lipid Nanoparticles.

trans-3-Methylglutaconyl CoA isomerization-dependent protein acylation.

Isomerization of -3-methylglutaconic acid.

Coenzyme Q nanodisks counteract the effect of statins on C2C12 myotubes.

Reconstituted HDL as a therapeutic delivery device.

Calcium-induced release of cytochrome c from cardiolipin nanodisks: Implications for apoptosis.

Inborn errors of metabolism associated with 3-methylglutaconic aciduria.

Foam fractionation of a recombinant biosurfactant apolipoprotein.

Role of non-enzymatic chemical reactions in 3-methylglutaconic aciduria.

Diversion of Acetyl CoA to 3-Methylglutaconic Acid Caused by Discrete Inborn Errors of Metabolism.

Cardiolipin nanodisks confer protection against doxorubicin-induced mitochondrial dysfunction.

Studies of the cardiolipin interactome.

Cardiac-specific deficiency of 3-hydroxy-3-methylglutaryl coenzyme A lyase in mice causes cardiomyopathy and a distinct pattern of acyl-coenzyme A-related biomarkers.

Lutein nanodisks protect human retinal pigment epithelial cells from UV light-induced damage.